Contingent Consideration - Reconciliation of the Beginning and Ending Balances Related to the Contingent Consideration (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2022	$ 54,110	$ 53,320	$ 54,967	$ 56,885	$ 56,142	$ 80,477	$ 54,967	$ 80,477
Milestone payments						(25,000)
Change in fair value recognized in earnings	(456)	790	(1,647)	486	743	665
Balance at September 30, 2023 (unaudited)	53,654	54,110	53,320	57,371	56,885	56,142	53,654	57,371
USWM Acquisition
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2022	45,220	44,560	46,270	47,240	46,890	70,170	46,270	70,170
Milestone payments						(25,000)
Change in fair value recognized in earnings	660	660	(1,710)	350	350	1,720	(400)	2,400
Balance at September 30, 2023 (unaudited)	45,880	45,220	44,560	47,590	47,240	46,890	45,880	47,590
Adamas Acquisition
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2022	8,890	8,760	8,697	9,645	9,252	10,307	8,697	10,307
Milestone payments						0
Change in fair value recognized in earnings	(1,116)	130	63	136	393	(1,055)	(900)	(500)
Balance at September 30, 2023 (unaudited)	$ 7,774	$ 8,890	$ 8,760	$ 9,781	$ 9,645	$ 9,252	$ 7,774	$ 9,781